SGLT2i After Kidney Transplantation: Ready for Prime Time?

Ross Simon Francis^{1

2}

Affiliations

¹ Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Australia.
² Faculty of Medicine, University of Queensland, Brisbane, Australia.

Editorial

Ross Simon Francis. Transplantation. 2022.

. 2022 Sep 1;106(9):1732-1733.

doi: 10.1097/TP.0000000000004227. Epub 2022 Jun 30.

Ross Simon Francis^{1

2}

¹ Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Australia.
² Faculty of Medicine, University of Queensland, Brisbane, Australia.

No abstract available

Comment on

The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients.
Lim JH, Kwon S, Jeon Y, Kim YH, Kwon H, Kim YS, Lee H, Kim YL, Kim CD, Park SH, Lee JS, Yoo KD, Son HE, Jeong JC, Lee J, Lee JP, Cho JH. Lim JH, et al. Transplantation. 2022 Sep 1;106(9):e404-e412. doi: 10.1097/TP.0000000000004228. Epub 2022 Jun 30. Transplantation. 2022. PMID: 35768908

1. van der Aart-van der Beek AB, de Boer RA, Heerspink HJL. Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol. 2022;18:294–306.
1. McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021;6:148–158.
1. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al.; DAPA-CKD Trial Committees and Investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436–1446.
1. Wheeler DC, Stefánsson BV, Jongs N, et al.; DAPA-CKD Trial Committees and Investigators. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9:22–31.
1. Schwaiger E, Burghart L, Signorini L, et al. Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety. Am J Transplant. 2019;19:907–919.